CH587261A5 - - Google Patents

Info

Publication number
CH587261A5
CH587261A5 CH708472A CH708472A CH587261A5 CH 587261 A5 CH587261 A5 CH 587261A5 CH 708472 A CH708472 A CH 708472A CH 708472 A CH708472 A CH 708472A CH 587261 A5 CH587261 A5 CH 587261A5
Authority
CH
Switzerland
Application number
CH708472A
Original Assignee
Kakenyaku Kako Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5233371A external-priority patent/JPS5020062B1/ja
Priority claimed from JP8610971A external-priority patent/JPS5020063B2/ja
Priority claimed from JP439572A external-priority patent/JPS5529993B2/ja
Application filed by Kakenyaku Kako Kk filed Critical Kakenyaku Kako Kk
Publication of CH587261A5 publication Critical patent/CH587261A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
CH708472A 1971-05-13 1972-05-12 CH587261A5 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3214571 1971-05-13
JP5233371A JPS5020062B1 (fr) 1971-07-14 1971-07-14
JP8610971A JPS5020063B2 (fr) 1971-10-28 1971-10-28
JP439572A JPS5529993B2 (fr) 1972-01-06 1972-01-06

Publications (1)

Publication Number Publication Date
CH587261A5 true CH587261A5 (fr) 1977-04-29

Family

ID=27454077

Family Applications (1)

Application Number Title Priority Date Filing Date
CH708472A CH587261A5 (fr) 1971-05-13 1972-05-12

Country Status (8)

Country Link
US (1) US3853923A (fr)
BE (1) BE783440A (fr)
CA (1) CA989411A (fr)
CH (1) CH587261A5 (fr)
DE (1) DE2223184C3 (fr)
FR (1) FR2137901B1 (fr)
GB (1) GB1380129A (fr)
NL (1) NL166939C (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457866A1 (fr) * 1979-05-29 1980-12-26 Anvar Nouveaux derives des cyano-2 hydroxy-3 benzofuranne et benzo(b) thiophene, leur preparation et leur application en therapeutique
JPS5639015A (en) * 1979-09-06 1981-04-14 Kaken Pharmaceut Co Ltd Ophthalmic solution for regulating intraocular tension
FR2515649A1 (fr) * 1981-10-30 1983-05-06 Debat Lab Nouveaux derives appartenant a la famille des 3-amino-1-heteroaryloxy-2-propanols, utilisation en therapeutique et procede de preparation
JPS58157784A (ja) * 1982-03-16 1983-09-19 Kaken Pharmaceut Co Ltd 光学活性な〔s〕−(+)−2−アセチル−7−(2,3−エポキシプロポキシ)ベンゾフランの製造法
JPS60202872A (ja) * 1984-03-27 1985-10-14 Kaken Pharmaceut Co Ltd ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤
ATE115953T1 (de) * 1987-12-11 1995-01-15 Mitsui Petrochemical Ind Amine und deren verwendung.
CA2355694A1 (fr) * 1998-12-18 2000-06-29 Yuhko Aoki Nouveaux composes bicycliques
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US10005750B2 (en) 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
CN107857748B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107827849B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 6-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107935972B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives

Also Published As

Publication number Publication date
NL166939C (nl) 1981-10-15
BE783440A (fr) 1972-09-01
FR2137901A1 (fr) 1972-12-29
CA989411A (en) 1976-05-18
US3853923A (en) 1974-12-10
DE2223184B2 (de) 1979-08-16
DE2223184C3 (de) 1980-04-30
NL166939B (nl) 1981-05-15
GB1380129A (en) 1975-01-08
FR2137901B1 (fr) 1975-10-31
DE2223184A1 (de) 1972-11-23
NL7206433A (fr) 1972-11-15

Similar Documents

Publication Publication Date Title
FR2137901B1 (fr)
AU2691671A (fr)
AU3005371A (fr)
AU2684071A (fr)
AU2742671A (fr)
AU2894671A (fr)
AU2941471A (fr)
AU2952271A (fr)
FR2146926B1 (fr)
AU2880771A (fr)
AU2684171A (fr)
AU3025871A (fr)
AU3038671A (fr)
AU2588771A (fr)
AU2940971A (fr)
AU2938071A (fr)
AU2930871A (fr)
AU2927871A (fr)
AU2907471A (fr)
AU2706571A (fr)
AU2755871A (fr)
AU2885171A (fr)
AU2724971A (fr)
AU2726271A (fr)
AU2740271A (fr)

Legal Events

Date Code Title Description
PL Patent ceased